MedTrace Logo

Evaluation of HEArt invoLvement in Patients With FABRY Disease

NCT03362164 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 650

Last updated 2022-07-07

No results posted yet for this study

Summary

This study evaluates predictors for the incidence of arrhythmias and sudden cardiac death as well as terminal heart failure in patients with Fabry disease.

Conditions

Sponsors & Collaborators

  • Competence Network Heart Failure

    collaborator OTHER

  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    collaborator OTHER

  • St George's, University of London

    collaborator OTHER

  • Wuerzburg University Hospital

    lead OTHER

Principal Investigators

  • Peter Nordbeck, MD, PhD · Wuerzburg University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-01-31
Primary Completion
2032-03-31
Completion
2032-03-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03362164 on ClinicalTrials.gov